Chemotherapy-induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention. [PDF]
Degliuomini MD +8 more
europepmc +1 more source
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial. [PDF]
Al-Samkari H +14 more
europepmc +1 more source
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia. [PDF]
Soff GA +6 more
europepmc +1 more source
A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. [PDF]
Al-Samkari H +5 more
europepmc +1 more source
A Case Study Using Papaya Leaf Extract to Reverse Chemotherapy-Induced Thrombocytopenia in a GBM Patient. [PDF]
Koehler A +6 more
europepmc +1 more source
Comparison of the real-world efficacy and safety of romiplostim and recombinant human thrombopoietin (rhTPO) in chemotherapy-induced thrombocytopenia. [PDF]
Cheng Y +7 more
europepmc +1 more source
A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors. [PDF]
Song B +7 more
europepmc +1 more source
[Clinical Study of San Wei Sheng Huo Decoction in the Treatment of Refractory Chemotherapy-Induced Thrombocytopenia]. [PDF]
Li R, Xiong SQ, He LF, Wu GY, Yuan YW.
europepmc +1 more source
Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study. [PDF]
Talreja V, Khatwani S, Subhagan P.
europepmc +1 more source
The efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Lai Y +7 more
europepmc +1 more source

